We focus on delivering functional improvement for people living with genetically driven neuromuscular diseases through targeted therapies enabled by our FORCE™ platform. We have assembled an exceptional team with deep experience in neuromuscular disease, rare disorders, drug development, and manufacturing and commercialization of novel therapeutics. We have also established a scientific advisory board comprised of leading experts in neuromuscular disease drug discovery and development.
Our leadership team
Our leadership team brings deep knowledge and extensive experience in the discovery, clinical development and commercialization of treatments for rare genetic diseases and novel therapeutic modalities.
John Cox, MBA
President and Chief Executive Officer
Doug Kerr, M.D., Ph.D., MBA
Chief Medical Officer
Erick J. Lucera
Chief Financial Officer
Oxana Beskrovnaya, Ph.D.
Chief Innovation Officer
Ranjan (Ron) Batra
Chief Scientific Officer
Johanna Friedl-Naderer
Chief Commercial Officer
Debra Feldman
Chief Regulatory Affairs Officer
Vikram (Vik) Ranade
Chief Business Officer
Raj Manchanda
Chief Technical Officer
James P. Bilotta, MBA
Chief Digital & Information Officer
Lucia Celona
Chief Human Resources Officer
José Juves
Senior Vice President, Corporate and Patient Affairs
Daniel Wilson
Senior Vice President, Head of Legal
Board of directors
Jason Rhodes
Chairman
John Cox
Ed Hurwitz
Carlo Incerti, M.D.
Dirk Kersten
David Lubner
Catherine Stehman-Breen
Scientific advisory board
Sudhir Agrawal, D.Phil.
Nancy Andrews, M.D., Ph.D.
Louis Kunkel, Ph.D.
Francesco Muntoni, FRCPCH, FMedSci
Jeffrey Statland, M.D.
Charles Thornton, M.D.
Contact us
For general inquiries, email us at info@dyne-tx.com.
To learn more about partnerships or working together, email us at partnerships@dyne-tx.com.
For investor and media inquiries, email us at ir@dyne-tx.com
Follow us on
Offices
1560 Trapelo Road
Waltham, MA 02451
Phone: 781.786.8230
Fax: 781.786.8866
